AI‑Enabled PERS Market Forecasts $11.5B by 2035, Fueling Vertical SaaS Growth
Future Market Insights projects the global Personal Emergency Response System (PERS) market to climb from $6.2 B in 2025 to $11.5 B by 2035, a 6.3% CAGR. The surge is driven by AI‑powered health‑monitoring SaaS platforms, mobile PERS devices, and expanding home‑healthcare adoption.
Why It Matters
The projected $11.5 billion market signals a maturing vertical SaaS segment where AI is not a bolt‑on feature but the core engine of value creation. For SaaS operators, the shift to subscription‑based PERS platforms offers a template for building high‑margin, recurring revenue models in other health‑tech niches. The growth of mobile PERS devices also illustrates how AI‑driven hardware can unlock new GTM channels, from direct‑to‑consumer sales to bundled offerings with insurers and home‑care providers.
For investors, the forecast validates a multi‑year runway for capital deployment in AI‑native health‑monitoring startups. The strong CAGR, especially in emerging markets like India, suggests that early‑stage players with scalable AI pipelines can capture sizable expansion revenue while establishing defensible data moats. The convergence of demographic pressure, policy support, and technology readiness creates a competitive moat for firms that can integrate AI analytics, device management, and care coordination into a single SaaS stack.
Key Points
- FMI projects global PERS market to grow from $6.2 B (2025) to $11.5 B (2035), a 6.3% CAGR
- Mobile PERS devices account for 54.3% of 2025 market revenue
- Home‑healthcare vertical holds 61.8% of 2025 market share
- India identified as fastest‑growing country with a 7.2% CAGR
- Projected $5.3 B incremental opportunity over the next decade
Analysis
The PERS forecast is more than a market size update; it marks the crystallization of a vertical SaaS archetype that blends AI, hardware, and subscription economics. Historically, emergency response solutions were sold as one‑off hardware with limited service contracts. The AI infusion transforms the product into a data engine, enabling continuous risk assessment and predictive alerts. This shift mirrors the broader SaaS evolution where the value proposition moves from static functionality to ongoing insight generation.
From a competitive standpoint, the market is poised for a classic "platformization" battle. Legacy device manufacturers that retrofit AI risk being outpaced by pure‑play SaaS firms that design AI pipelines from the ground up. The latter can iterate faster, integrate more tightly with telehealth and EHR ecosystems, and monetize data through ancillary services such as population health analytics. As a result, we can expect a wave of strategic acquisitions where larger health‑tech platforms absorb niche AI‑native PERS startups to accelerate time‑to‑market and secure data pipelines.
Finally, the macro‑demographic tailwinds—aging populations and chronic disease prevalence—create a durable demand base that is less susceptible to economic cycles. For SaaS operators, the lesson is clear: vertical specialization, when anchored by AI‑native capabilities, can generate high‑growth, high‑margin businesses that attract both enterprise customers and consumer users. The PERS market’s trajectory will likely serve as a blueprint for other health‑focused verticals, such as remote chronic disease management and AI‑driven mental‑health platforms, reinforcing the strategic importance of AI‑first SaaS models in the next decade.